Abstract
In this study, concentrations of amikacin in blood and bronchial secretions of 10 patients with mechanical ventilation for acute respiratory failure due to pneumonia were measured. One-half of the patients received amikacin twice daily, and the others received once-daily administration. Concentrations in bronchial secretions of the patients treated twice daily ranged from 3 to 4 mg/liter, i.e., they were similar to those in previously published reports. Peak concentrations in bronchial secretions occurred between 3 and 4 h after the onset of infusion, and they reached 4.8 +/- 2.6 mg/liter on day 1 and 4.0 +/- 2.7 mg/liter on day 3. For the patients treated with amikacin once daily, concentrations in bronchial secretions were more than twofold higher, above 8 mg/liter for 12 h. Peak concentrations in bronchial secretions occurred between 3 and 4 h after the onset of infusion and reached 13.6 +/- 9.3 mg/liter on day 1 and 10.4 +/- 3.5 mg/liter on day 3. These concentrations are higher than the MICs for less sensitive bacterial strains, such as Acinetobacter spp. and Pseudomonas aeruginosa.
Full Text
The Full Text of this article is available as a PDF (186.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beaucaire G., Leroy O., Beuscart C., Karp P., Chidiac C., Caillaux M. Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections. J Antimicrob Chemother. 1991 May;27 (Suppl 100):91–103. doi: 10.1093/jac/27.suppl_c.91. [DOI] [PubMed] [Google Scholar]
- Bergan T., Engeset A., Olszewski W. Does serum protein binding inhibit tissue penetration of antibiotics? Rev Infect Dis. 1987 Jul-Aug;9(4):713–718. doi: 10.1093/clinids/9.4.713. [DOI] [PubMed] [Google Scholar]
- Bergogne-Berezin E. Penetration of antibiotics into the respiratory tree. J Antimicrob Chemother. 1981 Sep;8(3):171–174. doi: 10.1093/jac/8.3.171. [DOI] [PubMed] [Google Scholar]
- Dull W. L., Alexander M. R., Kasik J. E. Bronchial secretion levels of amikacin. Antimicrob Agents Chemother. 1979 Dec;16(6):767–771. doi: 10.1128/aac.16.6.767. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Even P., Bergogne-Berezin E., Reynaud P., Berthelot G. Pharmacocinétique de l'amikacine dans les sécrétions bronchiques. Nouv Presse Med. 1979 Oct 31;8(42):3441–3444. [PubMed] [Google Scholar]
- Garraffo R., Drugeon H. B., Dellamonica P., Bernard E., Lapalus P. Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity. Antimicrob Agents Chemother. 1990 Apr;34(4):614–621. doi: 10.1128/aac.34.4.614. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Giamarellou H., Yiallouros K., Petrikkos G., Moschovakis E., Vavouraki E., Voutsinas D., Sfikakis P. Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic gram-negative infections. J Antimicrob Chemother. 1991 May;27 (Suppl 100):73–79. doi: 10.1093/jac/27.suppl_c.73. [DOI] [PubMed] [Google Scholar]
- Gilbert D. N. Once-daily aminoglycoside therapy. Antimicrob Agents Chemother. 1991 Mar;35(3):399–405. doi: 10.1128/aac.35.3.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klastersky J., Carpentier-Meunier F., Kahan-Coppens L., Thys J. P. Endotracheally administered antibiotics for gram-negative bronchopneumonia. Chest. 1979 May;75(5):586–591. doi: 10.1378/chest.75.5.586. [DOI] [PubMed] [Google Scholar]
- Klastersky J., Thys J. P., Mombelli G. Comparative studies of intermittent and continuous administration of aminoglycosides in the treatment of bronchopulmonary infections due to gram-negative bacteria. Rev Infect Dis. 1981 Jan-Feb;3(1):74–83. doi: 10.1093/clinids/3.1.74. [DOI] [PubMed] [Google Scholar]
- Maller R., Isaksson B., Nilsson L., Sörén L. A study of amikacin given once versus twice daily in serious infections. J Antimicrob Chemother. 1988 Jul;22(1):75–79. doi: 10.1093/jac/22.1.75. [DOI] [PubMed] [Google Scholar]
- Pennington J. E. Penetration of antibiotics into respiratory secretions. Rev Infect Dis. 1981 Jan-Feb;3(1):67–73. doi: 10.1093/clinids/3.1.67. [DOI] [PubMed] [Google Scholar]